Mesh Bio: Mesh Bio secures regulatory nod for device battling chronic kidney disease
According to the Singapore-based healthtech firm, HealthVector Diabetes is the world's first digital twin approved for clinical use.
Read full article »
Mesh Bio is a Singapore-based health-tech platform that provides solutions including health screening and result interpretation for healthcare providers.
Read more